Your browser doesn't support javascript.
loading
Relatively favorable outcome after allogeneic stem cell transplantation for BCR-ABL1-positive AML: A survey from the acute leukemia working party of the European Society for blood and marrow transplantation (EBMT).
Lazarevic, Vladimir Lj; Labopin, Myriam; Depei, Wu; Yakoub-Agha, Ibrahim; Huynh, Anne; Ljungman, Per; Schaap, Nicolaas; Cornelissen, Jan J; Maillard, Natacha; Pioltelli, Pietro; Gedde-Dahl, Tobias; Lenhoff, Stig; Houhou, Mohamed; Esteve, Jordi; Mohty, Mohamad; Nagler, Arnon.
Afiliação
  • Lazarevic VL; Skåne University Hospital, Department of Hematology, Oncology and Radiation Physics, Stem Cell Centre, Lund University, Lund, Sweden.
  • Labopin M; Hôpital Saint Antoine, ALWP office, Service d'Hématologie et de Thérapie cellulaire, Paris, France.
  • Depei W; First Affiliated Hospital of Soochow University, Department of Hematology, Suzhou Jiangsu, China.
  • Yakoub-Agha I; CHU de Lille, LIRIC, Université Lille, France.
  • Huynh A; Institut Universitaire du Cancer Toulouse, Oncopole, Toulouse, France.
  • Ljungman P; Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska University Hospital, Stockholm, Sweden.
  • Schaap N; Department of Hematology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands.
  • Cornelissen JJ; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, Netherlands.
  • Maillard N; Hopital La Miletrie, Head of the Bone Marrow Transplant Unit, Clinical Hematology, Poitiers, France.
  • Pioltelli P; Ospedale San Gerardo, Clinica Ematologica dell`Universita Milano-Biocca, Monza, Italy.
  • Gedde-Dahl T; Department of Hematology, Clinic for Cancer, Surgery and Transplantation, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
  • Lenhoff S; Skåne University Hospital, Department of Hematology, Oncology and Radiation Physics, Stem Cell Centre, Lund University, Lund, Sweden.
  • Houhou M; Hôpital Saint Antoine, ALWP office, Service d'Hématologie et de Thérapie cellulaire, Paris, France.
  • Esteve J; Hospital Clínic, IDIBAPS, Barcelona, Spain.
  • Mohty M; Hôpital Saint Antoine, ALWP office, Service d'Hématologie et de Thérapie cellulaire, Paris, France.
  • Nagler A; Hôpital Saint Antoine, ALWP office, Service d'Hématologie et de Thérapie cellulaire, Paris, France.
Am J Hematol ; 93(1): 31-39, 2018 01.
Article em En | MEDLINE | ID: mdl-28971504
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante Homólogo / Leucemia Mieloide Aguda / Transplante de Células-Tronco Hematopoéticas / Condicionamento Pré-Transplante Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Am J Hematol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Suécia País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante Homólogo / Leucemia Mieloide Aguda / Transplante de Células-Tronco Hematopoéticas / Condicionamento Pré-Transplante Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Am J Hematol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Suécia País de publicação: Estados Unidos